IndraLab

Statements


UCHL3 activates PARP1. 1 / 1
| 1

reach
"Overexpression of UCHL3 attenuated gefitinib-induced EGFR downregulation and increased PARP cleavage, while UCHL3 knockdown intensified these effects (Fig 2B)."